Read everything about IP finance and insurance in IAM’s latest Special Report
IAM’s Special Report 2024 Q2 "Money, money, money” reports deeply on the growing breadth of IP financial products spreading across the globe
IAM’s Special Report 2024 Q2 "Money, money, money” reports deeply on the growing breadth of IP financial products spreading across the globe
Over the last 18 months major developments have taken place in Lithuanian IP law, resulting from both new legislation and court decisions.
29 January 2008
It’s merger and acquisition (M&A) season: do you know where your intellectual property is? For the nearly 32,000 companies that have helped 2007 to be a record year for M&A activity, the answer should be yes. The federal regulators are watching.
29 January 2008
Pakistan has a large, growing pharmaceutical industry and generic manufacturing is on the rise. As a result, there have been a number of major infringements of patented processes for pharmaceuticals, as well as patented compounds and compositions by local generic manufacturers, which import the generic drugs or their active ingredients from China, Brazil and India and then formulate and/or repackage the drugs for sale in Pakistan.
29 January 2008
The value of owning patents continues to grow in the United States. As Alan Greenspan recently observed, “The economic product of the United States has become predominantly conceptual”.
29 January 2008
The smoke has cleared after the nearly decade-long battle between Microsoft and the European Commission, and competition practitioners and IP specialists alike are piecing through the decision to determine whether the boundaries between competition law and intellectual property have moved.
29 January 2008
Unlock unlimited access to all IAM content